1 "plus fluorouracil and leucovorin for metastatic colorectal cancer" 343 : 905-914, 2000
2 "Randomized trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer" 352 : 1407-1412, 1998
3 "Randomized trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer" 352 : 1413-1418, 1998
4 "Phase Ⅲ randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale" 23 : 4866-4875, 2005
5 "Phase Ⅱ trial of irinotecan in patients with metastatic colorectal carcinoma" 15 : 2910-2919, 1997
6 "Phase Ⅱ study of irinotecan, 5-fluorouracil, and leucovorin in relapsed or metastatic colorectal cancer as first-line therapy" 36 : 235-239, 2004
7 "Phase Ⅱ study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy" 15 : 251-260, 1997
8 "Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer" 14 : 1128-1135, 1996
9 "Irinotecan is an active agent in untreated patients with metastatic colorectal cancer" 14 : 709-715, 1996
10 "Irinotecan in the treatment of colorectal cancer: clinical overview" 19 : 1501-1518, 2001
1 "plus fluorouracil and leucovorin for metastatic colorectal cancer" 343 : 905-914, 2000
2 "Randomized trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer" 352 : 1407-1412, 1998
3 "Randomized trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer" 352 : 1413-1418, 1998
4 "Phase Ⅲ randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale" 23 : 4866-4875, 2005
5 "Phase Ⅱ trial of irinotecan in patients with metastatic colorectal carcinoma" 15 : 2910-2919, 1997
6 "Phase Ⅱ study of irinotecan, 5-fluorouracil, and leucovorin in relapsed or metastatic colorectal cancer as first-line therapy" 36 : 235-239, 2004
7 "Phase Ⅱ study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy" 15 : 251-260, 1997
8 "Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer" 14 : 1128-1135, 1996
9 "Irinotecan is an active agent in untreated patients with metastatic colorectal cancer" 14 : 709-715, 1996
10 "Irinotecan in the treatment of colorectal cancer: clinical overview" 19 : 1501-1518, 2001
11 "Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomized trial" 355 : 1041-1047, 2000
12 "Irinotecan combined with bolus fluorouracil, continuous infusion fluorouracil, and high- dose leucovorin every two weeks (LV5FU2 regimen): a clinical dose-finding and pharmacokinetic study in patients with pretreated metastatic colorectal cancer" 17 : 2901-2908, 1999
13 "Irinotecan combined with bolus fluorouracil and low-dose leucovorin every two weeks in patients with oxaliplatin pretreated metastatic colorectal cancer" 35 : 135-140, 2003
14 "Combination chemotherapy of irinotecan combined with bolus 5-fluorouracil, continuous infusion 5-fluorouracil, and high dose leucovorin every two weeks in recurrent or metastatic colorectal cancer" 64 : 452-458, 2003
15 "Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)" 35 : 54-59, 1999
16 "CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer" 35 : 1343-1347, 1999